Evidence map›Paper›PMID 42016617›Full record

ArticleClinical case reports2026

Staged Airway Stenting for Life-Threatening Tracheogastric Fistula (TGF) After Esophagectomy: A Case Report.

Xiaobing Wang, Zhan Zhang, Xiaoxue Zha, Meng Ling, Feihu Hu, Tingting Wang, Juan Zhang, Peishuang Wang, Xiaoyue Cui, Haiou Zhou and 1 more

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaobing WangDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.ORCID https://orcid.org/0000-0002-5491-7418
Zhan ZhangDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.
Xiaoxue ZhaDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.ORCID https://orcid.org/0009-0004-6145-5137
Meng LingDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.
Feihu HuDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.
Tingting WangDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.
Juan ZhangDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.
Peishuang WangDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.
Xiaoyue CuiDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.
Haiou ZhouDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.
Linlin ZhangDepartment of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China. Hefei Hefei Anhui China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tracheogastric fistula (TGF) is a rare but lethal complication following esophagectomy. Management of critical TGF cases with hemorrhage and respiratory failure remains challenging due to limited therapeutic options. We report a case of a 60-year-old man who developed life-threatening TGF with massive bleeding from the cervical anastomotic, airway, and thoracic drain sites 11 days postesophagectomy. Emergency bedside gastroscopy and bronchoscopy confirmed a left bronchial TGF. A staged intervention protocol was implemented: (1) Y-shaped airway stent placement during mechanical ventilation for hemorrhage control; (2) custom-made extended-length airway stent for precise fistula sealing; (3) combined negative-pressure drainage, targeted antibiotics, and nutritional support. After 36 days, complete fistula healing was achieved with stent removal. This case demonstrates that staged airway stenting with multimodal intensive care unit (ICU) support can successfully manage critical postesophagectomy TGF, providing a potential therapeutic paradigm for this devastating complication.

Indexed as

airway stentinganastomotic fistulaesophagectomytracheogastric fistula

Identifiers

PMID42016617
PMCPMC13093617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.